Patent details

Basic Information

Publication number:

EP3676261

PCT Application Number:

GB2018052479

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP187660212

PCT Publication Number:

WO2019043407

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

French Title of Invention:

DÉRIVÉS DE 2-AZABICYCLO[3.1.1]HEPTANE ET DE 2-AZABICYCLO[3.2.1]OCTANE SUBSTITUÉS EN TANT QU'ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE

German Title of Invention:

SUBSTITUIERTE 2-AZABICYCLO[ 3.1.1] HEPTAN UND 2-AZABICYCLO[ 3.2.1] OCTAN-DERIVATE ALS OREXIN-REZEPTOR-ANTAGONISTEN

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

14/01/2025

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

20/01/2025

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

18/12/2024

Unitary Effect Registration Date:

20/01/2025

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

31/08/2018

Grant date:

18/12/2024

EP Publication Date:

08/07/2020

PCT Publication Date:

07/03/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/12/2024

EP B1 Publication Date:

18/12/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

31/08/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/12/2024

 

 

Name:

Chronos Therapeutics Limited

Address:

TheraCryf Plc Alderley Park Congleton Road, Nether Alderley SK10 4TG, United Kingdom (GB)

Inventor

1

Name:

RAVEGLIA, Luca

Address:

Italy (IT)

2

Name:

MICHELI, Fabrizio

Address:

Italy (IT)

3

Name:

POZZAN, Alfonso

Address:

Italy (IT)

4

Name:

SEMERARO, Teresa

Address:

Italy (IT)

5

Name:

TARSI, Luca

Address:

Italy (IT)

6

Name:

LUKER, Timothy Jon

Address:

United Kingdom (GB)

7

Name:

GIBSON, Karl Richard

Address:

United Kingdom (GB)

8

Name:

BERTANI, Barbara

Address:

Italy (IT)

9

Name:

ZANALETTI, Riccardo

Address:

Italy (IT)

10

Name:

CREMONESI, Susanna

Address:

Italy (IT)

11

Name:

DI FABIO, Romano

Address:

Italy (IT)

Priority

1

Priority Number:

201714049

Priority Date:

01/09/2017

Priority Country:

United Kingdom (GB)

2

Priority Number:

201804745

Priority Date:

23/03/2018

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

C07D 401/14; C07D 413/14; C07D 401/10; C07D 417/06; C07D 417/10; C07D 417/14; C07D 471/04; C07D 487/04; C07D 498/04; C07D 513/04; A61K 31/439; A61P 25/30;

Publication

European Patent Bulletin

1

Issue number:

202451

Publication date:

18/12/2024

Description:

Grant (B1)

2

Issue number:

202508

Publication date:

19/02/2025

Description:

Unitary Effect Request Receipt

3

Issue number:

202508

Publication date:

19/02/2025

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages